Showing 10,321 - 10,340 results of 11,314 for search '"eventing"', query time: 0.11s Refine Results
  1. 10321

    Efficacy and Safety of Sofosbuvir-Based Direct-Acting Antiviral Agents Treatment for Patients with Genotype 3/6 Hepatitis C Virus Infection by Yong-yu Mei, You-ming Chen, Yuan-kai Wu, Xiao-hong Zhang, Wen-xiong Xu

    Published 2020-01-01
    “…The overall incidence rate of adverse events was 44.4%, with fatigue being the most common (13.0%). …”
    Get full text
    Article
  2. 10322

    A Small Increase in Serum Creatinine within 48 h of Hospital Admission Is an Independent Predictor of In-Hospital Adverse Outcomes in Patients with ST-Segment Elevation Myocardial... by Jiajia Zhu, Wenxian Liu, Jiang Li, Changsheng Ma, Dong Zhao

    Published 2023-01-01
    “…The primary outcome was the incidence of major adverse cardiovascular events (MACE). Secondary outcomes included the incidence of massive hemorrhage, in-hospital death, atrial fibrillation, heart failure, cardiogenic shock, cardiac arrest, and stroke. …”
    Get full text
    Article
  3. 10323

    Balloon dilation for the treatment of male urethral strictures: a systematic review and meta-analysis by Tianyu Cai, Xiaoyu Li, Jian Lin, Chunru Xu, Xing Ji, Zhenpeng Zhu, Zhenke Guo

    Published 2024-02-01
    “…The aim of this study was to review and discuss the safety, efficacy and factors influencing the clinical application of balloon dilation for the treatment of male urethral strictures.Design Systematic review and meta-analysis.Data sources Embase, Medline, Web of Science, Cochrane Library and Scopus were searched for publications published before 17 July 2022.Study selection Two independent researchers screened and assessed the results, and all clinical studies on balloon dilation for the treatment of urethral strictures in men were included.Data extraction and synthesis The success rate, rate of adverse events, International Prostate Symptom Scores, maximum uroflow (Qmax) and postvoid residual urine volume were the main outcomes. …”
    Get full text
    Article
  4. 10324

    Development and assessment of a mortality risk prediction nomogram model for pneumocystis disease in ICU within 28 days by Yiru Weng, Tingting Zhou, Honghua Ye

    Published 2025-01-01
    “…The bootstrap model’s 1000 internal validation results demonstrate that the model’s calibration performance is good and that its accuracy is highest when the probability of patient outcome events falls between 35 and 60%, which yields the highest net benefit for population prediction. …”
    Get full text
    Article
  5. 10325

    Genetic variation of the nuclear sequences of mitochondrial origin associated with retrotransposon Tv1 insertions in Drosophila species of the virilis group by B. V. Andrianov, D. A. Romanov, T. V. Gorelova

    Published 2018-11-01
    “…We applied this method to the detection and analysis of the nucleotide variability of the pseudogenes atp6 and cox3 associated with Tv1 insertions in a D. virilis cell culture and in the genomes of four Drosophila species of the virilis group: D. virilis, D. montana, D. borealis, and D. lacicola. We discovered new events of mitochondrial sequence transfer to the nucleus in the transplanted cell culture of D. virilis, and new Tv1 insertions, having emerged during the passage of this cell line were detected in the genome of the D. virilis transplanted cell culture. …”
    Get full text
    Article
  6. 10326

    Variability and clinical value of troponin T levels in diabetic kidney disease patients treated with dialysis by Yu Rui, Cheng Cui-cui, Zhang Shan, Yang Xiao-xia, Sun Xin-yu, Gao Qing-zhen

    Published 2025-01-01
    “…Elevated baseline TnT level is influenced by factors such as diabetic vascular complications, which can be used as a prognostic indicator for adverse events.…”
    Get full text
    Article
  7. 10327

    Characterizing Wellness Initiatives in Academic Radiation Oncology Departments by Sara Beltrán Ponce, MD, Crystal Seldon Taswell, MD, Idalid Franco, MD, MPH, Malcolm D. Mattes, MD, Tracy Kelly, MD, Leah Katz, MD, MPH

    Published 2025-02-01
    “…Challenges included limited bandwidth (66.7%), lack of funding (41.7%), and lack of departmental interest in organizing or attending events (33.3%). Leaders highlight the importance of a dedicated individual to tangibly implement changes and the unique opportunity of someone within RO to understand the specific challenges faced by those in our field. …”
    Get full text
    Article
  8. 10328

    Elevated Plasma Soluble Triggering Receptor Expressed on Myeloid Cells-1 Level in Patients with Acute Coronary Syndrome (ACS): A Biomarker of Disease Severity and Outcome by Shachaf Shiber, Vitaly Kliminski, Katia Orvin, Iftach Sagy, Mordehay Vaturi, Ran Kornowski, Michael Drescher, Yair Molad

    Published 2021-01-01
    “…Secondary endpoints were the association of plasma levels of sTREM-1 with day 30 and month 6 major adverse cardiovascular events (MACE) defined as death, ACS, stroke, and need for coronary revascularization, as well as with CAD severity. …”
    Get full text
    Article
  9. 10329

    Relationships between diabetes distress and biomarkers in people with type 1 diabetes mellitus by V.I. Pankiv, T.Yu. Yuzvenko, G.P. Mykhalchyshyn

    Published 2024-12-01
    “…Patients with a diagnosis of type 1 diabetes mellitus (T1DM) experience high levels of stress (stressful events and perceived stress) and psychological distress (symptoms of depression and anxiety) compared to people without diabetes. …”
    Get full text
    Article
  10. 10330

    Ezetimibe Improves Rosuvastatin Effects on Inflammation and Vascular Endothelial Function in Acute Coronary Syndrome Patients Undergoing PCI by Changqing Sun, Wuyang Zheng, Ling Liang, Zuheng Liu, Wenchao Sun, Rong Tang

    Published 2021-01-01
    “…Patients in the combination versus rosuvastatin group appeared to suffer from less major adverse events. Periprocedural therapy of ezetimibe improves rosuvastatin effects on proinflammatory responses and endothelial function associated with ACS patients undergoing PCI. …”
    Get full text
    Article
  11. 10331

    Long-term efficacy and safety of alemtuzumab in participants with highly active MS: TOPAZ clinical trial and interim analysis of TREAT-MS real-world study by Tjalf Ziemssen, Ann D. Bass, Bart Van Wijmeersch, Sara Eichau, Stephan Richter, Frank Hoffmann, Nicole M. Armstrong, Magdalena Chirieac, Janete Cunha-Santos, Barry A. Singer

    Published 2025-02-01
    “…Methods: Efficacy outcomes (annualized relapse rate (ARR), change in Expanded Disability Status Scale (EDSS), 6-month confirmed disability worsening/improvement, magnetic resonance imaging), and adverse events (AEs) were examined. Primary HAD definition (⩾2 relapses in the year prior to baseline and ⩾1 gadolinium-enhancing lesion at baseline), and two alternative HAD definitions were assessed. …”
    Get full text
    Article
  12. 10332

    Resilience-oriented passenger subsidy design for taxi travel under pandemic control by Lei Xia, Zhengfeng Huang, Gao Gao, Pengjun Zheng

    Published 2025-01-01
    “…Abstract Summarizing historical pandemic control experience can help the government better cope with the impact of uncertain public health events on taxi industry. This paper presents a summary of the relationship between various pandemic control measures and taxi system from the perspective of travel resilience. …”
    Get full text
    Article
  13. 10333

    Overlooking the Obvious during the COVID-19 Pandemic: Dyspnoea with Asymmetric Breath Sounds in a Toddler by Heli Salmi, Heini Harve-Rytsälä, Paula Rautiainen, Sari Pyörälä, Johanna Hästbacka

    Published 2021-01-01
    “…As the patient did not show clear signs of infection or bronchial obstruction, the events were thoroughly rediscussed with the caregiver next morning. …”
    Get full text
    Article
  14. 10334

    Efficacy of Weekly Split versus Single Doses of Ergocalciferol on Serum 25-Hydroxyvitamin D among Patients on Continuous Ambulatory Peritoneal Dialysis: A Randomized Controlled Tri... by Naowanit Nata, Jessada Kanchanasinitth, Pamila Tasanavipas, Ouppatham Supasyndh, Bancha Satirapoj

    Published 2021-01-01
    “…No significant cases of hypercalcemia, hyperphosphatemia, or serious adverse events occurred during the study. Conclusion. Weekly single and split doses of ergocalciferol 60,000 IU achieved similar effects on serum 25(OH)D levels among patients on CAPD with vitamin D insufficiency or deficiency, suggesting that weekly single dose would be prescribed for adequate vitamin D repletion. …”
    Get full text
    Article
  15. 10335

    Interventional effects of different track and field sports on human cardiovascular function indicators and physiological energy metabolism by Ruibin Jing, Zhengwei Wang, Choi Mee-Seong

    Published 2025-02-01
    “…Abstract Objective To analyze the effects of different track and field events on human cardiovascular function and physiological energy metabolism. …”
    Get full text
    Article
  16. 10336

    Pre-diabetes and cardiovascular risk factors in NAFLD patients: a retrospective comparative analysis by Azam Teimouri, Zahra Ebrahimpour, Awat Feizi, Bijan Iraj, Elahe Saffari, Mojtaba Akbari, Mozhgan Karimifar

    Published 2025-02-01
    “…The concurrence of pre-diabetes and NAFLD was a predicting factor for metabolic syndrome, but not CVD events.…”
    Get full text
    Article
  17. 10337

    Exploring effects of a booster workshop on progression and retention of resuscitation skills of residents when added to regular low-dose simulation by Hui-Wen Chen, Hung-Wei Tsai, Yi-Chun Chen, Yu-Jui Chiu, Enoch Yi-No Kang, Yi-Ting Hsu, S. Barry Issenberg, Jen-Chieh Wu

    Published 2025-01-01
    “…Abstract Background Improving the resuscitation and teamwork skills of residents is key to better outcomes of in-hospital cardiac arrest events. This study aims to explore the effects of regular low-dose simulation combined with a booster workshop on the progression and retention of resuscitation skills and teamwork among residents. …”
    Get full text
    Article
  18. 10338

    Association between triglyceride-glucose index and clinical outcomes among patients with chronic kidney disease: a meta-analysis by Jinli Tuo, Zhong Li, Linshen Xie

    Published 2025-02-01
    “…Secondary outcomes included the coronary artery disease (CAD) mortality, CKD progression, risk of severe coronary artery stenosis (SCAS), major adverse cardiovascular event (MACE), coronary artery calcification (CAC) progression, end-stage renal disease (ESRD), and nonalcoholic fatty liver disease (NAFLD). …”
    Get full text
    Article
  19. 10339

    Efficacy and safety of pembrolizumab in patients with advanced endometrial cancer: a systematic review and meta-analysis by Biqiong Pan, Xiaojun Lai, Jiefang Lu, Xiaoyan Bao, Zengke Fan, Jie Sun

    Published 2025-02-01
    “…Outcomes were progression-free survival (PFS), overall survival (OS), objective response rate (ORR), complete remission (CR), and adverse events (AEs); a subgroup analysis was carried out based on combination treatment regimens. …”
    Get full text
    Article
  20. 10340

    Safety profile of EZH2 inhibitors for cancer: a systematic review and meta-analysis by Zhou Zhao, Xiufeng Chen, Huayang Pang, Yan Shi, Hao Sun

    Published 2025-01-01
    “…Objective To evaluate the safety profiles of EZH2-targeted inhibitors in cancer treatment, focusing on treatment-related adverse events (TRAEs) across various clinical trials. Methods We conducted a systematic review and meta-analysis using data from clinical trials involving EZH2 inhibitors reported up to May 31, 2024. …”
    Get full text
    Article